Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04037254
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:03.290640+00:00
Published At
2025-07-11T00:00:00+00:00
Record Updated At
2026-04-06
Results Posted At
2025-07-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Prostate Adenocarcinoma", "Stage IIC Prostate Cancer AJCC v8", "Stage III Prostate Cancer AJCC v8", "Stage IIIA Prostate Cancer AJCC v8", "Stage IIIB Prostate Cancer AJCC v8", "Stage IIIC Prostate Cancer AJCC v8", "Stage IVA Prostate Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-06"
protocolSection.identificationModule.nctId
"NCT04037254"
protocolSection.identificationModule.officialTitle
"Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-07-11"

Study condition terms

  • Prostate Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage IIC Prostate Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Prostate Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Prostate Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Prostate Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Prostate Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Prostate Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.